Opko Health Inc. buy melinda
Start price
27.11.17
/
50%
€4.20
Target price
28.05.18
€6.00
Performance (%)
-23.50%
End price
28.05.18
€3.21
Summary
This prediction ended on 28.05.18 with a price of €3.21. The prediction for Opko Health Inc. disappointed with a performance of -23.50%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Opko Health Inc. | 6.533% | 6.533% | -5.069% | -31.833% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by melinda for this prediction
In the thread Opko Health Inc. diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 Ergebnisse Veröffentlichung
OPKO Health, Inc.
OPKO Health registriert seinen ersten Patienten in der Phase 2B von OPK88004 gutartiger Prostatahypertrophie zu behandeln
(Laufzeit überschritten)